Largest Series A financing round in Asia's diagnostic technology sector since 2019 underscores strong investor confidence in PHASE Scientific's breakthrough diagnostic technology and growth vision.

A grantee of the Gates Foundation, Hong Kong-based Phase Scientific built a business on the back of Covid-19 tests. Up next: using urine to compete with industry ‘gold standard’ HPV screening methods.

Hong Kong-headquartered biotech company PHASE Scientific International has completed a Series A funding round, raising $34m for progressing PHASIFY, a urine-based diagnostic technology for early ...

A Hong Kong-based developer of a catalog of urine-based tests for cancer, infectious diseases, women’s health and more has raised $34 million in venture capital funds to increase its global commercial ...